Dr. Christina Tise | Servant Leadership | Best Researcher Award

Dr. Christina Tise | Servant Leadership | Best Researcher Award

Stanford University, United States

Profile

Scopus 

Early Academic Pursuits 📚

Christina G. Tise, MD, PhD, embarked on her academic journey with a passion for the sciences, particularly in biochemistry. She pursued her undergraduate studies at Virginia Tech, where she obtained a Bachelor of Science in Biochemistry in May 2009. This foundational knowledge set the stage for her future work in medical genetics and genomics. During her time at Virginia Tech, Dr. Tise demonstrated a keen interest in how molecular biology could inform healthcare, leading her to pursue more specialized studies in the medical and genetic sciences.

In pursuit of her medical career, Dr. Tise entered the University of Maryland School of Medicine in 2010, where she completed her Doctor of Medicine (MD) degree in 2018. However, her academic pursuit did not stop there. While studying medicine, she simultaneously worked towards a PhD in Epidemiology and Human Genetics, with a focus on Human Genetics and Genomic Medicine. Her combined approach to MD and PhD studies allowed her to integrate clinical knowledge with a deep understanding of genetic research, particularly in genomics.

Professional Endeavors 🏥

Following her academic achievements, Dr. Tise’s professional career began to take shape at some of the most renowned institutions in the United States. She completed her internship in Pediatrics at Lucile Packard Children’s Hospital, Stanford, in 2019, which marked the start of her clinical journey. She continued her medical training with a residency in Medical Genetics at both Stanford University Medical Center and Lucile Packard Children’s Hospital. Her residency in medical genetics was a pivotal time in her career, as she honed her skills in diagnosing and managing genetic conditions in pediatric populations.

In 2021, Dr. Tise pursued a fellowship in Clinical Biochemical Genetics at Stanford University Medical Center and Lucile Packard Children’s Hospital. This specialized training further refined her expertise in biochemical genetics, a critical field for diagnosing metabolic and other genetic disorders that require advanced biochemical analysis. By June 2022, Dr. Tise’s impressive trajectory in medical genetics had earned her a prominent position as an Assistant Professor of Pediatrics in Medical Genetics at Stanford University, where she currently serves in this role.

Contributions and Research Focus 🔬

Dr. Tise’s research focuses on the intersection of human genetics and genomics, specifically in the field of medical genetics. Her PhD work at the University of Maryland School of Medicine centered on human genetics and genomic medicine, laying the groundwork for her subsequent research. In her clinical work, she has significantly contributed to the understanding of biochemical genetics, working on diagnostic strategies for complex genetic conditions.

As an academic physician, Dr. Tise’s research interests include the integration of genetic testing in clinical settings, advancing methodologies for diagnosing rare and inherited metabolic disorders, and leveraging genomic data to tailor patient care. She has published various studies on genetic disorders and their clinical implications, exploring how genomic data can improve precision medicine. Her research also touches on public health genetics, examining epidemiological patterns of genetic disorders and their environmental interactions.

Accolades and Recognition 🏅

Throughout her career, Dr. Tise has garnered recognition for her expertise and contributions to the field of medical genetics. She is board-certified by the American Board of Medical Genetics and Genomics in both Clinical Genetics and Genomics as well as Clinical Biochemical Genetics. These certifications speak to her depth of knowledge and clinical skills in genetics.

In addition to her academic qualifications, Dr. Tise holds a California Medical License and Drug Enforcement Administration (DEA) registration, enabling her to practice medicine and contribute to clinical research in her specialized areas. Her clinical and academic achievements have earned her a respected position in the field, where she continues to contribute to advancing medical genetics.

Impact and Influence 🌟

Dr. Tise’s work as an Assistant Professor at Stanford University has a significant impact on both her patients and the broader medical community. Through her clinical practice, she has directly influenced the care of patients with genetic disorders, particularly in pediatrics. Her research contributes to the body of knowledge in genetics, which in turn informs clinical practice, offering more accurate diagnostics and treatment strategies for genetic diseases.

Her educational role at Stanford also allows her to mentor and guide the next generation of geneticists and medical professionals. By training residents and fellows, she ensures that the latest genetic knowledge is passed on to those who will continue to innovate in the field. Through her commitment to both clinical care and research, Dr. Tise has become a vital force in the evolution of medical genetics.

Legacy and Future Contributions 🌱

Dr. Tise’s legacy is one of excellence in academic medicine, research, and clinical care. As she continues to make strides in the fields of genetic medicine and biochemistry, her contributions are setting the stage for groundbreaking work in genetic testing, diagnosis, and treatment. She is expected to have a long-lasting impact on how genetic conditions are understood and managed, particularly in pediatric populations.

Looking ahead, Dr. Tise plans to continue her research into the biochemical and genetic underpinnings of rare diseases. Her future work is likely to have a significant influence on personalized medicine, especially in the field of metabolic disorders. With her leadership at Stanford and her ongoing research endeavors, Dr. Tise will undoubtedly remain a key figure in the evolving field of medical genetics, pushing the boundaries of what is possible in genomic medicine and improving the lives of countless individuals affected by genetic conditions.

📝Notable Publications

Considerations for Reporting Variants in Novel Candidate Genes Identified During Clinical Genomic Testing

Authors: Chong, J.X., Berger, S.I., Baxter, S., Bamshad, M.J., Rehm, H.L.

Journal: Genetics in Medicine

Pages: 101199

Fetal Phenotype and Diagnosis of Autosomal Dominant Robinow Syndrome Due to Novel DVL1 Variant

Authors: Smith, C.M., Guinon, K., Bachir, S., Tise, C.G.

Journal: Prenatal Diagnosis

Year: 2024

Newborn Screening for X-Linked Adrenoleukodystrophy (X-ALD): Biochemical, Molecular, and Clinical Characteristics of Other Genetic Conditions

Authors: Mares Beltran, C.F., Tise, C.G., Barrick, R., Enns, G.M., Abdenur, J.E.

Journal: Genes

Year: 2024

Molecular Testing in Newborn Screening: VUS Burden Among True Positives and Secondary Reproductive Limitations via Expanded Carrier Screening Panels

Authors: Cook, S., Dunn, E., Kornish, J., Cusmano-Ozog, K.P., Tise, C.G.

Journal: Genetics in Medicine

Year: 2024

Monozygotic Twins Discordant for a Congenital Cranial Dysinnervation Disorder with Features of Moebius Syndrome

Authors: Gates, R.W., Webb, B.D., Stevenson, D.A., Ruzhnikov, M.R.Z., Tise, C.G.

Journal: American Journal of Medical Genetics, Part A

Year: 2023